NL-OMON43219招募中不适用
18F-FDHT PET/CT for re-staging patients with recurrent of prostate cancer after radiotherapy; a pilot study - FDHT PET/CT for restaging recurrent prostate cancer
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Histologically proven prostate cancer for which the subject has undergone radiotherapy with curative intent
- •- Biochemical recurrence according to Phoenix criteria (PSA nadir +2 ng/mL)
- •- PSA <10 ng/mL
- •- Written informed consent
- •- No androgen deprivation therapy in the past 12 months
- •- Planned for restaging or patients who have recently have been restaged with a mpMRI and 68 Ga-PSMA PET/CT (last scan not more than 28 days ago)
排除标准
- •- Active cancer besides prostate cancer
- •- Suspected metastases
- •- PSA > 10 ng/mL
- •- Androgen deprivation therapy in the past 12 months
- •- A contra-indication for undergoing MRI. (namely implants containing metal or metal schrapnels in the eyes or body and claustrophobia)
研究者
相似试验
尚未招募
不适用
FDHT PET/CT for radio-recurrent prostate cancerProstate cancerProstaatkankerNL-OMON21317PI: dr. I.J. de Jong, uroloog. UMCG20
已完成
不适用
Integrated 18F-FDG PET/CT in the staging of patients with suspected primary ovarian cancer.ovarian cancerNL-OMON29961Academisch Ziekenhuis Maastricht20
已完成
不适用
18F-FLT and 18F-FDG PET imaging for patients with non-small cell lung canceron-small cell lung cancerJPRN-UMIN000010636Third Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui80
已完成
Unknown
A retrospective study using 18F-FDG-PET/CT for the prediction of immunotherapy-related interstitial lung disease in lung cancer.Advanced or recurrent lung cancerJPRN-UMIN000053550iigata University Medical and Dental Hospital165
进行中（未招募）
不适用
FLT F-18 PET/CT in diagnosis, staging and terapy assessmentin tumours with accelereted replicatiopatients complying with cancer for whom is mandatory to know the replicative cellular activtyMedDRA version: 14.1Level: SOCClassification code 10022891Term: InvestigationsSystem Organ Class: 10022891 - InvestigationsMedDRA version: 14.1Level: SOCClassification code 10029104Term: Neoplasms benign, malignant and unspecified (incl cysts and polyps)System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2012-002820-33-ITCENTRO DI RIFERIMENTO ONCOLOGICO DI BASILICATA100